Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://med.cuhk.edu.hk/press-releases/cuhk-world-s-first-study-proves-myopia-in-children-can-be-prevented-by-low-concentration-atropine-eyedrops
https://med.cuhk.edu.hk/press-releases/cuhk-world-s-first-study-proves-myopia-in-children-can-be-prevented-by-low-concentration-atropine-eyedrops

CUHK world’s first study proves myopia in children can be prevented by low-concentration atropine eyedrops

Early onset of myopia is associated with high myopia later in life, and high myopia is associated with many sight-threatening conditions. The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) conducted a randomised, placebo-controlled, double-masked trial of low-concentration atropine eyedrops to evaluate their effectiveness in preventing myopia. Results show that among children aged four to nine years without myopia, compared with placebo, nightly use of low-concentration 0.05% atropine eyedrops resulted in a significant reduction in the incidence of myopia over two years, from 53.0% to 28.4% (a relative reduction of 46.4%). This is the first study in the world to prove that low-concentration atropine eyedrops can prevent the onset of myopia. Details of the study have been published in the renowned medical publication The Journal of the American Medical Association (JAMA). 

 

Myopia is a worldwide public health threat, with the highest prevalence in East Asia

 

Myopia is a worldwide public health threat with increasing prevalence across many regions in recent decades. A study published by the American Academy of Ophthalmology predicted that approximately half of the world’s population will be myopic by 2050, with the highest prevalence in East Asia, the region that includes Hong Kong. Professor Clement Tham Chee-yung, Chairman and S. H. Ho Professor of Ophthalmology and Visual Sciences from the Department of Ophthalmology and Visual Sciences at CU Medicine, remarked, “The increasing prevalence of myopia concerns many countries. For example, the Central Government in the Mainland aims to set up a mechanism covering all counties and districts across the country by the end of 2025 that can track myopia rates among youngsters and detect the factors that influence them. In Hong Kong, we have noticed that the COVID-19 pandemic has triggered a myopia boom in school children due to school closure and social distancing measures. Strategies to prevent myopia onset and to reduce its progression have become paramount.”

 

Prof Calvin Pang

Professor Calvin Pang states that myopia is irreversible and the earlier its onset, the greater the likelihood of high myopia occurring later in life. .

Professor Clement Tham

Professor Clement Tham states that the COVID-19 pandemic has triggered a myopia boom in school children due to school closure and social distancing measures.

 

Early onset of myopia leads to an increased risk of high myopia and many sight-threatening conditions

 

Myopic individuals have a higher risk of sight-threatening complications that lead to poor vision and even blindness. “Myopia can be caused by excessive elongation of the eyeball,” said Professor Calvin Pang Chi-pui, S. H. Ho Research Professor of Visual Sciences from the Department of Ophthalmology and Visual Sciences at CU Medicine and Director of the Shantou University / The Chinese University of Hong Kong Joint Shantou International Eye Centre. “This disease is irreversible once it has developed and the earlier its onset, the greater the likelihood of high myopia occurring later in life. Glaucoma, macular degeneration, retinal detachment and cataracts are all complications of high myopia. The eyeball elongation problem cannot be corrected by wearing glasses or having laser refractive surgery, and thus the risk of complications cannot be reduced. Therefore, prevention or delay of myopia onset should be given top priority.” 
 

Additional myopia prevention strategies are warranted for high-risk children

 

Studies have confirmed that the only way to prevent myopia and delay the myopia onset was to increase the time for outdoor activities. Dr Zhang Xiujuan, Research Assistant Professor from the Department of Ophthalmology and Visual Sciences at CU Medicine, said, “In a previous trial conducted in Mainland China, increasing outdoor class time by 40 minutes daily was proven to reduce the three-year cumulative incidence of myopia in children by 23%. Although encouraging children to spend more time outdoors is an effective approach, additional strategies are warranted, especially for children at high risk of developing myopia. Children whose parents are both myopic, have 12 times the risk of developing myopia compared to those whose parents are nonmyopic.” 

 

Low-concentration atropine eyedrops can prevent myopia in children

 

The CU Medicine research team recruited 474 nonmyopic children aged four to nine years at the CUHK Eye Centre to join the randomised, placebo-controlled, double-masked “Low-Concentration Atropine for Myopia Prevention (LAMP2)” trial from 2017 to 2020. The participants had at least one parent who is myopic. They were randomly assigned to the 0.05% atropine group, the 0.01% atropine group, or the placebo group and had eyedrops applied once nightly in both eyes for two years. 

 

Results showed that the 0.05% atropine group had a significantly lower two-year cumulative incidence of myopia and a lower percentage of participants with fast myopic shift, compared with the placebo group (see details below):

 

0.05% Atropine group
 

0.01% Atropine group

Placebo group
 

Two-year cumulative incidence of myopia

28.4%

45.9%

53.0%

Percentage of participants with fast myopic shift at two years

25.0%

45.1%

53.9%

Percentage of participants reporting photophobia
(the most common adverse reaction)

12.9%

18.9%

12.2%

 

Dr Jason Yam

Dr Jason Yam demonstrates the application of low-concentration 0.05% atropine eyedrops.

Dr Jason Yam Cheuk-sing, Principal Investigator of the LAMP2 Study, Associate Professor from the Department of Ophthalmology and Visual Sciences, CU Medicine and Director of the CUHK Jockey Club Myopia Prevention Programme, stated, “Our previous LAMP1 study proved that low-concentration atropine eyedrops can reduce myopia progression and a 0.05% concentration appeared to achieve the best balance between maximising efficacy and minimising side effects. The current LAMP2 study has further shown their potential in preventing myopia onset. As our younger generation becomes more reliant on digital devices and we are facing a surge in myopia in the future, our findings suggest low-concentration atropine eyedrops is an effective preventive strategy for myopia onset among high-risk children and reduce their risk of suffering from sight-threatening diseases.”   

 

The team plans to launch a LAMP3 study to investigate the efficacy and safety of combining atropine eyedrops with red light therapy. Interested individuals can contact the research team by WhatsApp (91371925) or email (childreneye@cuhk.edu.hk).

 

More Press Releases

CUHK Study First Proves Low-Concentration Atropine Eye Drops Reduce Myopia Progression in Children with Minimal Side Effects

CUHK Study First Proves Low-Concentration Atropine Eye Drops Reduce Myopia Progression in Children with Minimal Side Effects

Research
CUHK study reveals prevalence of myopia in children has reached record high in Hong Kong Number of myopic children aged six is double after COVID-19 restrictions Low-concentration atropine eyedrops with red light therapy study launched

CUHK study reveals prevalence of myopia in children has reached record high in Hong Kong Number of myopic children aged six is double after COVID-19 restrictions Low-concentration atropine eyedrops with red light therapy study launched

Research
CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children  During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

Research
CUHK study opens up a new treatment direction for autoimmune eye inflammation

CUHK study opens up a new treatment direction for autoimmune eye inflammation

Research
CUHK study reveals 1 in 5 Hong Kong children have moderate to severe astigmatism Strong parental astigmatism influence observed

CUHK study reveals 1 in 5 Hong Kong children have moderate to severe astigmatism Strong parental astigmatism influence observed

Research
A CUHK-led international team develops the world’s first AI model using fundus photographs alone to detect Alzheimer’s disease

A CUHK-led international team develops the world’s first AI model using fundus photographs alone to detect Alzheimer’s disease

Research
A new technology ROTA developed by HKUMed and CU Medicine can visualise axonal fibre bundles on the retina to advance early diagnosis of glaucoma and optic neuropathies

A new technology ROTA developed by HKUMed and CU Medicine can visualise axonal fibre bundles on the retina to advance early diagnosis of glaucoma and optic neuropathies

Research
CU Medicine study shows a higher prevalence of dry eye disease  among post-COVID-19 patients

CU Medicine study shows a higher prevalence of dry eye disease among post-COVID-19 patients

Research
CUHK Establishes Lam Kin Chung . Jet King-Shing Ho Glaucoma Treatment and Research Centre  To Promote Advancement in Glaucoma Management in Hong Kong through Research and Training

CUHK Establishes Lam Kin Chung . Jet King-Shing Ho Glaucoma Treatment and Research Centre To Promote Advancement in Glaucoma Management in Hong Kong through Research and Training

Donation
CUHK Receives Nearly HKD 78 Million from HKJC to Launch Ophthalmic Programmes for Children’s Eye Care and Ophthalmic Microsurgical Training

CUHK Receives Nearly HKD 78 Million from HKJC to Launch Ophthalmic Programmes for Children’s Eye Care and Ophthalmic Microsurgical Training

Donation
CUHK Launches World’s First Study Utilizing Retinal Imaging for Alzheimer’s Disease Screening in Chinese Population

CUHK Launches World’s First Study Utilizing Retinal Imaging for Alzheimer’s Disease Screening in Chinese Population

Research
CUHK Pao So Kok Macular Disease Treatment and Research Centre Opens Study Sees Correlation between Protein Angiopoietin2 and Wet Age-related Macular Degeneration

CUHK Pao So Kok Macular Disease Treatment and Research Centre Opens Study Sees Correlation between Protein Angiopoietin2 and Wet Age-related Macular Degeneration

Donation
CUHK Launches Vision Screening for Hong Kong Children

CUHK Launches Vision Screening for Hong Kong Children

Clinical service
CUHK Research Reveals Use of Ortho-K Lens as a Major Risk Factor for Microbial Keratitis in School Children

CUHK Research Reveals Use of Ortho-K Lens as a Major Risk Factor for Microbial Keratitis in School Children

Research
The Lee Wing Kit Advanced Ophthalmic Training and Education Centre Opens Today

The Lee Wing Kit Advanced Ophthalmic Training and Education Centre Opens Today

Donation

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.